# An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects

> **NCT02793154** · PHASE4 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 4 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Albiglutide

## Key facts

- **NCT ID:** NCT02793154
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09-26
- **Primary completion:** 2017-03-16
- **Final completion:** 2017-03-16
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Early termination due to insufficient enrollment.
- **Last updated:** 2020-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02793154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02793154, "An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02793154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*